Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Smith is an oncologist in Ann Arbor, MI and is affiliated with the University of Michigan Medical Center and Michigan Medicine. He received his medical degree from University of Washington School of Medicine and has been in practice 32 years. He specializes in genitourinary oncology and is experienced in clinical trials, prostate and bladder cancer, and testicular neoplasms.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1989 - 1992
University of WashingtonResidency, Internal Medicine, 1985 - 1988- University of Washington School of MedicineClass of 1985
Certifications & Licensure
MI State Medical License 1995 - 2027
PA State Medical License 1992 - 1996
NC State Medical License 1990 - 1995
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Circulating tumor DNA is a useful adjunct for Merkel cell carcinoma monitoring in the context of multiple metastatic malignancies.Daniel Wenzel, Andrew M Schuler, David C Smith, Joseph R Evans, Kelly L Harms
JAAD Case Reports. 2024-10-01 - Incidental testicular germ cell tumor in a transgender woman: A case report.R Evey Aslanian, Cole Roblee, David C Smith, Rohit Mehra, William M Kuzon Jr
Urology Case Reports. 2024-09-01 - Outpatient administration of paclitaxel, ifosfamide, and cisplatin (TIP) for germ cell tumor.Allison J Schepers, David C Smith, Rachel L McDevitt
Journal of Oncology Pharmacy Practice. 2023-06-01
Journal Articles
- Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer ImmunotherapyDavid Smith, Sarah Yentz, Biodrugs
Press Mentions
David Smith Retires with a Legacy of Compassionate Patient CareOctober 16th, 2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
